American Association for Cancer Research
can-23-0193_figure_s1_suppsf1.docx (1.21 MB)

Figure S1 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer

Download (1.21 MB)
journal contribution
posted on 2023-11-01, 07:43 authored by Zhihang Chen, Guopei Zhang, Xiaoxue Ren, Zhijia Yao, Qian Zhou, Xuxin Ren, Shuling Chen, Lixia Xu, Kaiyu Sun, Qianwen Zeng, Ming Kuang, Dong-Ming Kuang, Sui Peng

Figure S1


National Natural Science Foundation of China (NSFC)

Science and Technology Program of Guangzhou, China

Fundamental Research Funds for the Central Universities (Fundamental Research Fund for the Central Universities)



The tumor microenvironment is distinctive in primary and secondary liver cancer. B cells represent an important component of immune infiltrates. Here, we demonstrated that B cells are an important regulator in hepatocellular carcinoma (HCC) and colorectal cancer liver metastasis (CRLM) microenvironments. B cells displayed distinct developmental trajectories in HCC and CRLM. Single-cell analysis revealed that IgG+ plasma cells preferentially accumulated in HCC, whereas IgA+ plasma cells were preferentially enriched in CRLM. Mechanistically, IgG+ plasma cells in HCC were recruited by tumor-associated macrophages via the CXCR3–CXCL10 axis, whereas IgA+ plasma cells in CRLM were recruited by metastatic tumor cells via CCR10–CCL28 signaling. Functionally, IgG+ plasma cells preferentially promoted protumorigenic macrophages formation in HCC, and IgA+ plasma cells preferentially induced granulocytic myeloid-derived suppressor cells activation in CRLM. Clinically, increased infiltration of IgG+ plasma cells and macrophages in HCC was correlated to worse survival, whereas increased intratumoral IgA+ plasma cells and neutrophils in CRLM indicated poor prognosis. Taken together, this study demonstrated plasma and myeloid cell-mediated immunosuppression in HCC and CRLM, suggesting that selectively modulating primary or secondary tumor-related immunosuppressive regulatory networks might reprogram the microenvironment and provide an immunotherapeutic strategy for treating liver cancer. The immunomodulatory patterns of tumor-infiltrating B cells are distinct in primary and secondary liver cancer, with plasma cells mediating important physiologic processes that drive cancer progression.

Usage metrics

    Cancer Research





    Ref. manager